Qutenza Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Qutenza General Information

Description

Developer of pharmaceutical drugs. The company offers Qutenza (capsaicin) 8% patch, a dermal delivery system containing prescription strength capsaicin. It is used for management of neuropathic pain associated with postherpetic neuralgia

Contact Information

Website
www.qutenza.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Acorda Therapeutics
Primary Office
  • 420 Saw Mill River Road
  • Ardsley, NY 10502
  • United States
+1 (877) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Qutenza Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Qutenza‘s full profile, request access.

Request a free trial

Qutenza Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Qutenza‘s full profile, request access.

Request a free trial